The current understanding of sepsis and research priorities for the future

Virulence

Volumn 5, Issue 1, 2014, Pages 1-3

  Opal, Steven ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Bacterial toxins; Clinical trials; Endotoxin; Host pathogen interactions; Innate immunity; Sepsis; Septic shock

Indexed keywords

ANTIINFECTIVE AGENT; VACCINE;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; HUMAN; IMMUNE RESPONSE; NONHUMAN; RESEARCH; SEPSIS; SEPTIC SHOCK;

BACTERIAL TOXINS; CLINICAL TRIALS; ENDOTOXIN; HOST-PATHOGEN INTERACTIONS; INNATE IMMUNITY; SEPSIS; SEPTIC SHOCK;

BIOMEDICAL RESEARCH; HUMANS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84891657793     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.26803     Document Type: Editorial

References (29)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-51. PMID:23984731; http://dx.doi.org/10.1056/ NEJMra1208623
2. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014; Forthcoming
3. Angele MK, Pratschke S, Hubbard WJ, Chaudry IH. Gender differences in sepsis: Cardiovascular and immunological aspects. Virulence 2014; Forthcoming. PMID:24193307; http://dx.doi.org/10.4161/viru.26982
4. Balk RA. Systemic inflammatory response syndrome (SIRS): Where did it come from and is it still relevant today? Virulence 2014; Forthcoming
5. Marshall JC. The PIRO (Predisposition, Insult, Response, Organ Dysfunction) model: Towards a staging system for acute illness. Virulence 2014; Forthcoming. PMID:24184604; http://dx.doi. org/10.4161/viru.26908
6. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet 2013; 381:774-5. PMID:23472921; http://dx.doi.org/10.1016/ S0140-6736(12)61815-7
7. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014; Forthcoming. PMID:23774844; http://dx.doi.org/10.4161/viru.25436
8. Boomer JS, Green JM, Hotchkiss S. The changing immune system in sepsis: Is individualized immunemodulatory therapy the answer? Virulence 2014; Forthcoming. PMID: 24067565; http://dx.doi. org/10.4161/viru.26516
9. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-8. PMID:23427891; http://dx.doi.org/10.1016/S1473-3099(13)70001-X
10. Christaki E, Giamarellos-Bourboulis EJ. The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host. Virulence 2014; Forthcoming. PMID:24067507; http://dx.doi. org/10.4161/viru.26514
11. Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014; Forthcoming. PMID:24185508; http://dx.doi. org/10.4161/viru.26907
12. DeBacker D, Cortes O, Donadello K, Vincent J-L. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence 2014; Forthcoming. PMID: 24067428; http://dx.doi. org/10.4161/viru.26482
13. Kumar A. An alternate pathophysiologic paradigm of sepsis and septic shock: Implications for optimizing antimicrobial therapy. Virulence 2014; Forthcoming. PMID:24184742; http://dx.doi.org/10.4161/ viru.26913
14. Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence 2014; Forthcoming. PMID:24104403; http://dx.doi.org/10.4161/ viru.26515
15. Reglinski M, Sriskandan S. The contribution of group A streptococcal virulence determinants to the pathogenesis of toxic shock syndrome. Virulence 2014; Forthcoming. PMID:24157731; http://dx.doi. org/10.4161/viru.26400
16. Florescu DF, Kalil AC. The complex link between influenza and severe sepsis. Virulence 2014; Forthcoming
17. Fink MP. Animal models of sepsis. Virulence 2014; Forthcoming. PMID:24022070; http://dx.doi. org/10.4161/viru.26083
18. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al.; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110:3507-12. PMID:23401516; http://dx.doi.org/10.1073/ pnas.1222878110
19. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014; Forthcoming
20. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 2014; Forthcoming. PMID:24157707; http:/dx.doi. org/10.4161/viru.26187
21. Shah BA, Padbury JF. Neonatal sepsis: An old problem with new insights. Virulence 2014; Forthcoming. PMID:24185532; http://dx.doi. org/10.4161/viru.26906
22. Randolph AG, McCulloh RJ. Pediatric sepsis: Important considerations for diagnosing and managing severe infections in infants, children and adolescents. Virulence 2014; Forthcoming
23. Schorr CA, Zanotti S, Dellinger RP. Management of severe sepsis and septic shock. Virulence 2014; Forthcoming
24. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637. PMID:23353941; http://dx.doi.org/10.1097/CCM.0b013e31827e83af
25. Finfer S. Clinical controversies in the management of critically ill patients with severe sepsis: Resuscitation fluids and glucose control. Virulence 2014Forthcoming. PMID:23921249; http:// dx.doi.org/10.4161/viru.25855
26. Pop-Vicas A, Opal SM. The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock. Virulence 2014Forthcoming; http://dx.doi.org/10.4161/viru.26210
27. Ramachandran G. Gram-positive and gram-negative toxins in the context of sepsis. Virulence 2014; Forthcoming. PMID:24193365; http://dx.doi. org/10.4161/viru.27024
28. Cross AS. Anti-endotoxin vaccines: Back to the future. Virulence 2014; Forthcoming. PMID:23974910; http://dx.doi.org/10.4161/viru.25965
29. Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 2014; Forthcoming. PMID:23973944; http://dx.doi.org/10.4161/viru.25991